COM:CULLINANONCOLOGY
Cullinan Oncology
- Stock
Last Close
12.22
22/11 21:00
Market Cap
923.88M
Beta: -
Volume Today
464.95K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
net income | -14.19M - | -21.65M 52.61% | -59.46M 174.58% | -67.48M 13.50% | 109.19M 261.81% | -153.16M 240.26% | |
depreciation and amortization | 43K - | 70K 62.79% | 62K 11.43% | 53K 14.52% | 93K 75.47% | 310K 233.33% | |
deferred income tax | -4K - | 233K 5,925% | 3.10M 1,229.61% | -31.23M - | |||
stock based compensation | 17K - | 14.91M 87,605.88% | 24.38M 63.48% | 27.96M 14.70% | 30.44M 8.87% | ||
change in working capital | 345K - | 135K 60.87% | 6.85M 4,974.81% | -3.54M 151.69% | 11.18M 415.62% | -339K 103.03% | |
accounts receivables | |||||||
inventory | |||||||
accounts payables | 225K - | 639K 184% | 5.58M 773.40% | -4.83M 186.63% | -509K 89.47% | -167K 67.19% | |
other working capital | 120K - | -504K 520% | 1.27M 351.98% | 1.29M 1.89% | 11.69M 803.01% | -172K 101.47% | |
other non cash items | 252K - | 539K 113.89% | 7.63M 1,315.58% | 67K 99.12% | -275.08M 410,674.63% | 19.70M 107.16% | |
net cash provided by operating activities | -13.55M - | -20.90M 54.23% | -29.77M 42.47% | -43.43M 45.89% | -126.66M 191.63% | -134.28M 6.01% | |
investments in property plant and equipment | -261K - | -20K 92.34% | -10K 50% | -589.23K 5,792.25% | -1.13M 92.29% | -208K 81.64% | |
acquisitions net | 1.45M - | 923K 36.34% | 275M 29,694.15% | ||||
purchases of investments | -35.38M - | -69.76M 97.18% | -525.81M 653.71% | -377.92M 28.13% | -373.38M 1.20% | ||
sales maturities of investments | 62.90M - | 192.04M 205.29% | 352.93M 83.78% | 409.40M 16.00% | |||
other investing activites | -333.77K - | 91K 127.26% | |||||
net cash used for investing activites | -261K - | -35.40M 13,463.22% | -5.42M 84.69% | -333.77M 6,058.21% | 248.97M 174.59% | 35.81M 85.62% | |
debt repayment | -2.20M - | -1.82M 17.05% | |||||
common stock issued | 1K - | 85.72M 8,571,400% | 140.14M 63.50% | 267.27M 90.71% | 6.02K 100.00% | 38.93M 646,511.30% | |
common stock repurchased | -21K - | -378K 1,700% | -213K 43.65% | ||||
dividends paid | |||||||
other financing activites | -9K - | 378K 4,300% | 213K 43.65% | 1.52M 611.74% | -23.74M 1,665.90% | 3.65M 115.38% | |
net cash used provided by financing activities | -29K - | 85.72M 295,668.97% | 140.14M 63.50% | 268.78M 91.80% | -25.93M 109.65% | 40.75M 257.14% | |
effect of forex changes on cash | |||||||
net change in cash | -13.84M - | 29.42M 312.57% | 104.95M 256.75% | -108.42M 203.31% | 96.38M 188.89% | -57.72M 159.89% | |
cash at beginning of period | 47.67M - | 33.83M 29.03% | 63.25M 86.95% | 168.20M 165.93% | 59.77M 64.46% | 156.15M 161.24% | |
cash at end of period | 33.83M - | 63.25M 86.95% | 168.20M 165.93% | 59.77M 64.46% | 156.15M 161.24% | 98.43M 36.96% | |
operating cash flow | -13.55M - | -20.90M 54.23% | -29.77M 42.47% | -43.43M 45.89% | -126.66M 191.63% | -134.28M 6.01% | |
capital expenditure | -261K - | -20K 92.34% | -10K 50% | -589.23K 5,792.25% | -1.13M 92.29% | -208K 81.64% | |
free cash flow | -13.81M - | -20.92M 51.46% | -29.78M 42.38% | -44.02M 47.81% | -127.80M 190.30% | -134.48M 5.23% |
All numbers in (except ratios and percentages)